Checkpoint Therapeutics, Inc.,

a Fortress Biotech Company, is an innovative, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel, targeted non-chemotherapy, and immune-enhanced combination treatments for patients with solid tumor cancers.

read more >